Overview

Empagliflozin Effect on Glucose Toxicity

Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
Empagliflozin effect on glucose toxicity in type 2 diabetes patients - a randomized, open-label, controlled, parallel group, exploratory study
Phase:
Phase 4
Details
Lead Sponsor:
GWT-TUD GmbH
University Hospital Tuebingen
Treatments:
Empagliflozin
Insulin
Insulin Glargine
Insulin, Globin Zinc